To see all protocols that comply with the WHO Essential Medicine List 

Welcome to eviQ

A free resource of evidence-based, consensus driven cancer treatment protocols and information for use at the point of care. eviQ is developed for the Australian context and supports health professionals in the delivery of cancer treatments.

Find out more

 

Latest news

View all news

Information for health professionals and people with cancer, as they deal with the impact of COVID-19 can be found via the link.

The COVID-19 situation is changing rapidly. eviQ is aware of the increasing pressures facing the health care system and individual clinicians. We are reassessing all of our reference committee meetings for the first half of 2020.

Radiation therapy centres may be considering shorter fractionation schedules to reduce the number of treatment visits for patients. Fractionation schedule guidelines can be found on RANZCR’s COVID-19 College Taskforce radiation oncology practice guidance page.

The production of L-asparaginase (also known as colaspase or brand name Leunase) has been discontinued by the manufacturer. This will impact a number of eviQ protocols.